Institutional Ownership Clearside Biomedical, Inc. (CLSD)
This table provides information about the institutional ownership of Clearside Biomedical, Inc. (CLSD). We have compiled data on the 54 institutions that hold shares in the stock, with a total of 13.4 Million shares, which have been reported (via 13F filing form) to have a value of $13.9 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
2,839,978
shares
|
$2.95 Million
0.0% of portfolio
|
Q2 2024
Added 14.02%
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
2,197,480
shares
|
$2.29 Million
3.43% of portfolio
|
Q3 2022
Reduced 3.96%
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
2,136,000
shares
|
$2.22 Million
0.04% of portfolio
|
Q2 2024
Reduced 46.01%
|
|
Carmignac Gestion
Paris, I0 |
Aug 13, 2024 Q2 2024 |
2,132,744
shares
|
$2.22 Million
0.05% of portfolio
|
Q3 2023
Reduced 11.15%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
798,137
shares
|
$830,062
0.0% of portfolio
|
Q2 2024
Added 5.26%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
672,297
shares
|
$699,188
0.0% of portfolio
|
Q2 2024
Added 4.68%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
582,689
shares
|
$605,996
0.0% of portfolio
|
Q2 2024
Added 6.57%
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
257,103
shares
|
$267,387
0.0% of portfolio
|
Q3 2024
Reduced 9.21%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
205,163
shares
|
$213,369
0.0% of portfolio
|
Q2 2024
Added 6.1%
|
|
First Manhattan CO
New York, NY |
Aug 15, 2024 Q2 2024 |
175,000
shares
|
$182,000
0.0% of portfolio
|
Q1 2018
Reduced 50.0%
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
145,990
shares
|
$151,829
0.0% of portfolio
|
Q2 2024
Reduced 4.61%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
133,451
shares
|
$138,789
0.0% of portfolio
|
Q2 2024
Reduced 0.06%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2024 Q2 2024 |
130,000
shares
|
$135,200
0.0% of portfolio
|
Q2 2024
Reduced 0.15%
|
|
Brown Wealth Management, LLC
Naperville, IL |
Aug 13, 2024 Q2 2024 |
100,000
shares
|
$104,000
0.05% of portfolio
|
Q2 2024
Reduced 9.09%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
96,630
shares
|
$100,495
0.0% of portfolio
|
Q2 2024
Added 37.7%
|
|
Northeast Financial Consultants Inc
Westport, CT |
Aug 15, 2024 Q2 2024 |
93,000
shares
|
$96,720
0.01% of portfolio
|
Q4 2023
Added 12.05%
|
|
Captrust Financial Advisors
Raleigh, NC |
Aug 14, 2024 Q2 2024 |
87,000
shares
|
$90,480
0.0% of portfolio
|
Q2 2024
Added 74.0%
|
|
Marshall Wace, LLP
London, X0 |
Aug 14, 2024 Q2 2024 |
62,117
shares
|
$64,601
0.0% of portfolio
|
Q2 2024
Reduced 9.27%
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2024 Q2 2024 |
54,313
shares
|
$56,485
0.01% of portfolio
|
Q2 2024
Added 172.19%
|
|
Synovus Financial Corp
Columbus, GA |
Aug 13, 2024 Q2 2024 |
53,071
shares
|
$55,193
0.0% of portfolio
|
Q1 2024
Reduced 8.61%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
42,889
shares
|
$44,604
0.0% of portfolio
|
Q2 2024
Reduced 79.27%
|
|
Banque Cantonale Vaudoise
|
Jul 31, 2024 Q2 2024 |
40,000
shares
|
$41,600
0.0% of portfolio
|
Q4 2022
New holding
|
|
Prudential Financial Inc
Newark, NJ |
Aug 13, 2024 Q2 2024 |
35,400
shares
|
$36,816
0.0% of portfolio
|
Q2 2024
Added 75.25%
|
|
Stifel Financial Corp
St. Louis, MO |
Aug 13, 2024 Q2 2024 |
30,544
shares
|
$31,765
0.0% of portfolio
|
Q2 2024
Reduced 21.77%
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
28,693
shares
|
$29,840
0.0% of portfolio
|
Q2 2024
Reduced 83.76%
|